{"id":"https://openalex.org/W2963972855","doi":"https://doi.org/10.1007/s40262-019-00801-0","title":"SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies","display_name":"SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies","publication_year":2019,"publication_date":"2019-07-24","ids":{"openalex":"https://openalex.org/W2963972855","doi":"https://doi.org/10.1007/s40262-019-00801-0","mag":"2963972855","pmid":"https://pubmed.ncbi.nlm.nih.gov/31338688","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6994455"},"language":"en","primary_location":{"id":"doi:10.1007/s40262-019-00801-0","doi":"https://doi.org/10.1007/s40262-019-00801-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-019-00801-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-019-00801-0.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40262-019-00801-0.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109432700","display_name":"Ethan C. Hoffmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ethan Hoffmann","raw_affiliation_strings":["Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA. ethan@sagerx.com","Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA. ethan@sagerx.com","institution_ids":["https://openalex.org/I4210131505"]},{"raw_affiliation_string":"Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000780851","display_name":"George G. Nomikos","orcid":"https://orcid.org/0000-0003-2846-1426","observed_orcids":["https://orcid.org/0000-0003-2846-1426"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]},{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George G. Nomikos","raw_affiliation_strings":["Clinical Develoment, Biogen, Cambridge, MA, USA","Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Develoment, Biogen, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017547567","display_name":"Inder Kaul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inder Kaul","raw_affiliation_strings":["Kaul Consulting, LLC, Concord, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaul Consulting, LLC, Concord, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013002662","display_name":"Shane R. Raines","orcid":"https://orcid.org/0009-0007-0637-8476","observed_orcids":["https://orcid.org/0009-0007-0637-8476"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shane Raines","raw_affiliation_strings":["2b Analytics, LLC, Wallingford, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2b Analytics, LLC, Wallingford, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111425940","display_name":"Jeff Wald","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeff Wald","raw_affiliation_strings":["qPharmetra, LLC, Cary, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"qPharmetra, LLC, Cary, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066703519","display_name":"Amy E. Bullock","orcid":"https://orcid.org/0000-0002-7237-6205","observed_orcids":["https://orcid.org/0000-0002-7237-6205"]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Bullock","raw_affiliation_strings":["Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073452309","display_name":"Abdul J. Sankoh","orcid":"https://orcid.org/0009-0001-2618-0447","observed_orcids":["https://orcid.org/0009-0001-2618-0447"]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdul J. Sankoh","raw_affiliation_strings":["Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108402200","display_name":"James Doherty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Doherty","raw_affiliation_strings":["Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001147138","display_name":"Stephen Kanes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen J. Kanes","raw_affiliation_strings":["Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085068964","display_name":"Helen Colquhoun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen Colquhoun","raw_affiliation_strings":["Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc., 215 First Street, Cambridge, MA, 02412, USA","institution_ids":["https://openalex.org/I4210131505"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109432700"],"corresponding_institution_ids":["https://openalex.org/I4210131505"],"apc_list":{"value":3760,"currency":"USD","value_usd":3760},"apc_paid":{"value":3760,"currency":"USD","value_usd":3760},"fwci":2.1884,"has_fulltext":true,"cited_by_count":59,"citation_normalized_percentile":{"value":0.87903077,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"59","issue":"1","first_page":"111","last_page":"120"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9042999744415283,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9042999744415283,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.018200000748038292,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.7770000100135803},{"id":"https://openalex.org/keywords/positive-allosteric-modulators","display_name":"positive allosteric modulators","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9509999752044678},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7319999933242798},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dose-finding","display_name":"dose-finding","score":0.6370000243186951},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.7519999742507935},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.765999972820282},{"id":"https://openalex.org/keywords/postpartum-depression","display_name":"postpartum depression","score":0.890999972820282},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9000518918037415},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7208976149559021},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7123339772224426},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6562235951423645},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.597711980342865},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5787113904953003},{"id":"https://openalex.org/C2775870830","wikidata":"https://www.wikidata.org/wiki/Q3379200","display_name":"SAGE","level":2,"score":0.557182788848877},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.45447856187820435},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.43022334575653076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31728827953338623},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C185544564","wikidata":"https://www.wikidata.org/wiki/Q81197","display_name":"Nuclear physics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010601","descriptor_name":"Pharmacology, Clinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011278","descriptor_name":"Pregnanes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011278","descriptor_name":"Pregnanes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011278","descriptor_name":"Pregnanes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011280","descriptor_name":"Pregnanolone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019052","descriptor_name":"Depression, Postpartum","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D019052","descriptor_name":"Depression, Postpartum","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D019052","descriptor_name":"Depression, Postpartum","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s40262-019-00801-0","doi":"https://doi.org/10.1007/s40262-019-00801-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-019-00801-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-019-00801-0.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5963550","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6994455","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6994455","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6994455","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Pharmacokinet","raw_type":"Text"},{"id":"pmid:31338688","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31338688","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacokinetics","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1007/s40262-019-00801-0","doi":"https://doi.org/10.1007/s40262-019-00801-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-019-00801-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-019-00801-0.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320315149","display_name":"Sage Therapeutics","ror":"https://ror.org/03t9rxt77"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2963972855.pdf","grobid_xml":"https://content.openalex.org/works/W2963972855.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W123609371","https://openalex.org/W135939678","https://openalex.org/W1964544239","https://openalex.org/W1987266621","https://openalex.org/W1994775090","https://openalex.org/W2002716918","https://openalex.org/W2018692234","https://openalex.org/W2024077111","https://openalex.org/W2037631502","https://openalex.org/W2057823239","https://openalex.org/W2084236159","https://openalex.org/W2106279703","https://openalex.org/W2114645992","https://openalex.org/W2137976898","https://openalex.org/W2138425268","https://openalex.org/W2142051176","https://openalex.org/W2148083007","https://openalex.org/W2154223842","https://openalex.org/W2156962505","https://openalex.org/W2356354199","https://openalex.org/W2375106168","https://openalex.org/W2531903693","https://openalex.org/W2598012653","https://openalex.org/W2610210587","https://openalex.org/W2626607634","https://openalex.org/W2740680044","https://openalex.org/W2874089935","https://openalex.org/W2889396010","https://openalex.org/W4250501176"],"related_works":["https://openalex.org/W2805550027","https://openalex.org/W2784856799","https://openalex.org/W2613313253","https://openalex.org/W2780388179","https://openalex.org/W2609268752","https://openalex.org/W2740680044","https://openalex.org/W4399913537","https://openalex.org/W4396915194","https://openalex.org/W2920812218","https://openalex.org/W4231794793"],"abstract_inverted_index":{"SAGE-217,":[0],"a":[1,54,137,144],"novel":[2],"\u03b3-aminobutyric":[3],"acid":[4],"A":[5,7,110],"(GABA":[6],")":[8],"receptor":[9],"positive":[10],"allosteric":[11],"modulator,":[12],"was":[13,133,179,209,217],"evaluated":[14],"in":[15,117,121,128,159],"phase":[16,230],"I,":[17],"double-blind,":[18],"placebo-controlled,":[19],"single":[20,55],"ascending":[21,26],"dose":[22,27,56,100],"(SAD)":[23],"and":[24,34,79,106,125,143,162,170,183,203,213,234,241],"multiple":[25,229],"(MAD)":[28],"studies":[29,164,236],"to":[30,53,65,167,205],"assess":[31],"the":[32,46,72,118,122,129,154,160,199],"safety":[33],"pharmacokinetics":[35],"(PK)":[36],"of":[37,57,112,140,147,157,237],"SAGE-217":[38,58,81,132,158,178,208,224],"following":[39],"administration":[40],"as":[41],"an":[42],"oral":[43,155],"solution.":[44],"In":[45,71,94,175],"SAD":[47,123,161],"study,":[48,74],"subjects":[49,75,120,127],"were":[50,76,108,165,189,193],"randomized":[51,77],"6:2":[52],"or":[59,84,87],"placebo.":[60],"Doses":[61],"ranged":[62],"from":[63],"0.25":[64],"66":[66],"mg":[67,172],"across":[68],"nine":[69],"cohorts.":[70],"MAD":[73,130,163],"9:3":[78],"received":[80],"(15,":[82],"30,":[83],"35":[85],"mg)":[86],"placebo":[88],"once":[89],"daily":[90],"for":[91,153],"7":[92],"days.":[93],"both":[95,176],"studies,":[96,177],"PK,":[97],"maximum":[98],"tolerated":[99],"(MTD;":[101],"against":[102],"predetermined":[103],"criteria),":[104],"safety,":[105],"tolerability":[107],"assessed.":[109],"total":[111],"108":[113],"healthy":[114],"volunteers":[115],"enrolled":[116],"studies\u201472":[119],"study":[124],"36":[126],"study.":[131],"orally":[134],"bioavailable,":[135],"with":[136],"terminal-phase":[138],"half-life":[139],"16\u201323":[141],"h":[142],"t":[145,200],"max":[146,201],"approximately":[148],"1":[149],"h.":[150],"The":[151],"MTDs":[152],"solution":[156],"determined":[166],"be":[168],"55":[169],"30":[171],"daily,":[173],"respectively.":[174],"generally":[180,210],"well":[181,211,218],"tolerated,":[182,212],"no":[184],"serious":[185],"adverse":[186],"events":[187],"(SAEs)":[188],"reported.":[190],"Most":[191],"AEs":[192],"mild,":[194],"dose-dependent,":[195],"transient,":[196],"occurred":[197],"around":[198],",":[202],"related":[204],"drug":[206],"pharmacology.":[207],"its":[214],"PK":[215],"profile":[216],"characterized.":[219],"Based":[220],"on":[221],"this":[222],"profile,":[223],"has":[225],"been":[226],"advanced":[227],"into":[228],"II":[231],"clinical":[232],"programs":[233],"pivotal":[235],"major":[238],"depressive":[239],"disorder":[240],"postpartum":[242],"depression.":[243]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":18},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-07-30T00:00:00"}